Taste signalling molecules are found in the gastrointestinal (GI) tract suggesting that they participate to chemosensing. We tested whether fasting and refeeding affect the expression of the taste signalling molecule, a-transducin (G atran ), throughout the pig GI tract and the peptide content of G atran cells. The highest density of G atran -immunoreactive (IR) cells was in the pylorus, followed by the cardiac mucosa, duodenum, rectum, descending colon, jejunum, caecum, ascending colon and ileum. Most G atran -IR cells contained chromogranin A. In the stomach, many G atran -IR cells contained ghrelin, whereas in the upper small intestine many were gastrin/cholecystokinin-IR and a few somatostatin-IR. G atran -IR and G agust -IR colocalized in some cells. Fasting (24 h) resulted in a significant decrease in G atran -IR cells in the cardiac mucosa (29.3 AE 0.8 versus 64.8 AE 1.3, P < 0.05), pylorus (98.8 AE 1.7 versus 190.8 AE 1.9, P < 0.0 l), caecum (8 AE 0.01 versus 15.5 AE 0.5, P < 0.01), descending colon (17.8 AE 0.3 versus 23 AE 0.6, P < 0.05) and rectum (15.3 AE 0.3 versus 27.5 AE 0.7, P < 0.05). Refeeding restored the control level of G atran -IR cells in the cardiac mucosa. In contrast, in the duodenum and jejunum, G atran -IR cells were significantly reduced after refeeding, whereas G atran -IR cells density in the ileum was not changed by fasting/refeeding. These findings provide further support to the concept that taste receptors contribute to luminal chemosensing in the GI tract and suggest they are involved in modulation of food intake and GI function induced by feeding and fasting.
Introduction
Sensing of luminal contents by the gastrointestinal (GI) tract mucosa plays a critical role in the control of digestion, absorption, food intake and metabolism [1, 2] by triggering functional responses appropriate for beneficial or potentially harmful substances. Enteroendocrine (EEC) cells act as specialized transducers of luminal content, by releasing signalling molecules, which activate nerve fibres as well as local and distant targets to influence gut functions. EECs can be either 'open-type' or 'closed-type' depending on their microvilli reaching or not the lumen [1] [2] [3] . Both types of cells can be regulated by intraluminal content, either directly ('open cells') or indirectly ('closed cells') through neural and humoural mechanisms to release a variety of secretory products, including gastrin (G cells), ghrelin (P or X cells), somatostatin (D cells), cholecystokinin (CCK) (I cells), serotonin (enterochromaffin cells), glucose-dependent insulinotropic peptide (GIP) (K cells), glucagon-like peptides (GLPs) and peptide YY (PYY) (L cells), according to the different substances detected in the lumen [1] [2] [3] . Once released, these signalling molecules affect different functions ranging from gastrointestinal motility and secretion to feeding regulation via the brain-gut axis [1] [2] [3] .
The discovery that taste receptors (TRs) and signalling molecules identified in the oral cavity are expressed in the GI mucosa, suggests that they play a role in chemosensing in the gut. TRs are G proteincoupled receptors (GPCRs) sensing bitter (T2Rs), or sweet and umami (T1Rs) tastes. T2Rs are a large family of receptors (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) in mammals) perceiving a multitude of tastants, whereas T1Rs comprise 3 receptors that heterodimerize to sense sweetness (T1R2 and T1R3) or umami (T1R1 and T1R3) [4] [5] [6] . T1Rs and T2Rs mediate gustatory signalling by interacting with specific Ga subunits, including a-gustducin (G agust ) and a-transducin (G atran ) [7] through the activation of different effector systems leading to intracellular Ca 2+ increase and transmitter release. G agust or G atran immunoreactivity (IR) has been localized to epithelial EECs and non-EECs in the rodent [8] [9] [10] [11] , pig [12, 13] and human [14] GI tract and pancreatic duct [15] .
The aims of this study were to characterize the cellular sites of expression of G atran and test the hypothesis that G atran is modulated by fasting and refeeding in the GI tract of the pig, an animal model closer to humans compared with rodents for food intake, body size, lifespan and body proportion.
Materials and methods
Large White male pigs (n = 12), of about 45 days of age with an average weight of 12.0 AE 0.3 kg, purchased from Suidea (Reggio Emilia, Italy), were fed with a standard balanced diet and housed individually in pens with a mesh floor in a temperature-controlled room and tap water freely available. Following 1 day adaptation, animals were divided into three groups: standard diet (control, n = 4), fasted for 24 h (fasted, n = 4) and refed for 24 h after fasting (refed, n = 4). Experimental procedures were approved by the Ethic Committee for Experimental Animals of the University of Bologna, Italy.
Pigs were deeply anaesthetized with sodium thiopental (10 mg/kg body weight, Zoletil 100, Virbac) and killed by an intracardiac injection of Tanax â (0.5 ml/kg BW; Intervet Italia). Specimens of the GI tract: oesophagus (cervical, thoracic and abdominal tract), stomach (cardiac, near to the gastric diverticulum; oxyntic, in the greater curvature; and pyloric, close to the pyloric sphincter), duodenum (about 10 cm from the pyloric sphincter), middle jejunum and ileum, caecum, ascending colon (near the centrifugal turns), descending colon (about 25 cm from the anus) and rectum (in the ampulla recti) were collected, pinned flat on balsa wood, fixed in 10% buffered formalin for 24 h at room temperature (RT), dehydrated and embedded in paraffin.
Immunohistochemistry
Serial (5 lm thick) sections mounted on poly-L-lysine-coated slides were processed for single and double labelling immunofluorescence using antibodies directed to G atran or G agust , chromogranin A (CgA), a generalized marker for EECs, or specific markers for EEC subtypes (ghrelin, GHR, somatostatin, SOM and gastrin/cholecystokinin GAS/ CCK) (Table 1) . Briefly, sections were deparaffinized through graded ethanols to xylene, rehydrated and heated in sodium citrate buffer (pH 6.0) in a microwave (2 cycles at 800 W, 5 min each) for antigen unmasking. Sections were incubated in 15% normal horse serum/ 0.01 M phosphate buffer saline (PBS) (1 h at RT) to prevent non-specific staining, followed by primary antibodies in PBS (overnight) and a mixture of fluorescein isothiocyanate (FITC)-conjugated, tetramethyl rhodamine isothiocyanate (TRITC)-conjugated, Alexa Fluor â 594-and Alexa Fluor â 488-conjugated secondary antibodies all diluted in PBS (Table 1) , then coverslipped with buffered glycerol, pH 8.6. As the antibodies to G atran and G agust were generated in the same species, serial sections (3 lm thick) were used to test their colocalization.
Specificity of antibodies
Specificity of G atran , G agust and GAS/CCK antibodies has been tested by Western blot (Supplementary material) whereas specificity of CgA monoclonal antibody (clone LK2H10) has been previously reported [16] . GHR antibody specificity was assessed by pre-adsorption with an excess of the homologous peptide (sc-10368 P, Santa Cruz, CA, USA) or another ghrelin peptide (code 031-52; Phoenix Pharmaceuticals, Inc., Burlingame, CA, USA). The pattern obtained with our S6 SOM antibody completely 
Cell counting and statistical analysis
Cell counting was performed with a 40 9 objective lens using a Zeiss Axioplan microscope (Carl Zeiss, Oberkochen, Germany) with appropriate filter cubes to discriminate different wave fluorescence, images were collected with a Polaroid DMC digital photocamera (Polaroid, Cambridge, Mass., USA) and minimal adjustment to brightness and contrast was performed with Corel Photo Paint and Corel Draw (Corel, Dublin, Ireland).
Cell counting was performed in a blind fashion by two investigators. For each piglet, G atran -IR cells were counted in 36 random microscope fields (each field, 0.28 mm 2 ), for a total area of 10 mm 2 , in the cardiac, oxyntic and pyloric mucosa, in 50 random villi and glands in the small intestine, and in 50 crypts in the colon. Only villi/glands/crypts located perpendicularly to the mucosal surface were counted. The values were pooled for each experimental group (control, fasted and refed respectively) and, subsequently, the mean and the percentage were calculated. Values were expressed as mean AE standard deviation (SD). Data were analysed using ANOVA One-Way (Graph Prism 4, GraphPad Software, Inc., La Jolla, CA, USA). Statistical significance was determined using the Student's t-test. A P < 0.05 was considered statistically significant.
Results

Distribution of G atran -IR cells in the GI tract
G atran -IR cells were detected throughout the whole pig GI tract ( Fig. 1A-G) , except the oesophagus and oxyntic mucosa. In the pylorus, intense G atran -IR was observed in the basal portion of the gastric gland and in the epithelial lining of the mucosal folds ( Fig. 1A and F); G atran -IR cells had elongated, 'bottle-like', morphology with homogenously labelled cytoplasm ( Fig. 1E and G). In the small intestine, a subset of cells along the crypt-villus axis showed G atran -IR (Fig. 1B , E and G), whereas in the large intestine, labelled cells were generally located in the surface and glandular epithelium (Fig. 1C and D) . Most G atran -IR cells had two thin cytoplasmic prolongations, one extending to the endoluminal mucosal surface ( Fig. 1E and G) and one to the basal lamina, suggesting they are 'EEC open-type' cells [1, 3] . In the cardiac and pyloric mucosa, some cells were confined to the basal lamina and did not reach the lumen (Fig. 1F) , like 'EEC closed-type' cells [1, 3] .
Distribution of the G atran -IR cells in different experimental groups
In the stomach, the highest density of G atran -IR cells was in the pylorus (there was an average of about 18.9 cells/mm 2 or 5.3 cells per field); in the small intestine, the highest density of G atran -IR cells was in the duodenum followed by the jejunum and ileum, whereas in the large intestine it was in the rectum followed by descending colon, caecum and ascending colon ( Fig. 2A and B) . There was a decrease in the density of G atran -IR cells in fasted animals, which was significant in the cardiac mucosa (29.3 AE 0.8 versus 64.8 AE 1.3, P < 0.05 versus control), pylorus (98.8 AE 1.7 versus 190.8 AE 1.9, P < 0.0 l), caecum (8 AE 0.01 versus 15.5 AE 0.5, P < 0.01), descending colon (17.8 AE 0.3 versus 23 AE 0.6, P < 0.05) and rectum (15.3 AE 0.3 versus 27.5 AE 0.7, P < 0.05), but not in the other regions. Interestingly, refeeding restored the control level of G atran -IR cells in the cardiac mucosa (57 AE 1 versus 29.3 AE 0.8 in fasted, P < 0.01), but not in the pylorus, caecum, descending colon and rectum where the number of G atran -IR cells in refed was comparable to fasted pigs. In the jejunum, G atran -IR cells in the refed group were less than in the fasted condition and were significantly lower than in controls (9.3 AE 0.2 in refed versus 19 AE 0.3 in control, P < 0.01). In the ileum and ascending colon, the number of G atran -IR cells in fasted and refed animals was comparable to controls.
G atran /CgA in the GI tract
The majority of G atran -IR cells co-expressed CgA: 99% of the G atran -IR cells in the cardiac and pyloric mucosa were immunopositive for CgA, whereas 83% and 98% of G atran -IR cells were immunopositive for CgA in the small and large intestine respectively. However, some cells were G atran -IR, but CgA negative ( Fig. 1 G and H) . In the stomach, G atran -IR/CgA-IR cells were numerous in the glandular epithelium.
The mean numbers of G atran /CgA-IR cells throughout the pig gut are reported in Table 2A . In the cardiac mucosa, the mean number of G atran /CgA-IR cells in control and refed groups is higher than that of fasted group (P < 0.05). In the pyloric mucosa, the mean number of G atran /CgA-IR cells in fasted and refed groups was lower than control (control versus fasted and control versus refed, P < 0.05). A general decrease in G atran /CgA-IR cells was observed in the small and large intestine in fasted and refed compared with control. Specifically, in the duodenum and jejunum, the G atran /CgA-IR cells were significantly decreased in refed compared with control (P < 0.05). Moreover, in the duodenum, we found a reduced number of G atran /CgA-IR cells in refed compared with fasted (P < 0.05). G atran /CgA-IR cells were more abundant in the caecum, descending colon and rectum of control group compared with fasted (P < 0.05), whereas in the caecum and in the rectum, refed showed a number of G atran /CgA-IR lower than control (P < 0.05). The percentage of the G atran on the total of CgA-IR cells have been indicated in Table 2B . Furthermore, there were no statistically significant differences in the absolute numbers of CgA-IR cells in the gastric and intestinal mucosa among the three experimental groups.
G atran /GHR in the gastric mucosa G atran /GHR-IR cells were numerous in the pylorus, from the neck to the base of the glands (Fig. 3A and B) , and less abundant in cardiac glands ( Fig. 3C and D) . Most G atran /GHR cells were 'closed-type', lying at the gland basal lamina. Few G atran /GHR-IR cells in the surface epithelium were 'open-type' (Fig. 3C and D) . In the cardiac and pyloric mucosa, approximately 96% and 91% of G atran -IR cells, respectively, co-expressed GHR. G atran /GHR-IR cells were significantly reduced in fasted versus control pigs in both cardiac mucosa (P < 0.01) and pylorus (P < 0.05). In refed, they were partly restored in the cardiac mucosa (P < 0.05), but not pylorus. The mean number and percentage of the G atran on the total of GHR-IR cells are reported in Table 3 . In the cardiac mucosa, the number of GHR-IR cells decreased in fasted versus control (114.8 AE 29.4 versus 244.5 AE 71.3, P < 0.01), while it increased in refed versus fasted (241.3 AE 57.5 versus 114.8 AE 29.4, P < 0.01). There were no statistically significant differences in the mean numbers of GHR-IR cells in the pyloric mucosa among the three experimental groups.
Colocalization of G atran with CCK, SOM and G agust in the duodenum and jejunum Co-expression of G atran and CCK was observed in open-type cells in the surface and glandular epithelium of the jejunum (Fig. 3E-H ). As our monoclonal antibody cannot discriminate CCK and GAS, we could not assess the actual number of GAS and CCK-IR cells in the duodenum where both cell types are present. Few G atran /SOM cells (about 1 positive cell/400 villi) were detected ( Fig. 4A and B) . The mean number and percentage of the G atran compared with the total number of CCK-IR cells are reported in Table 4 . In the jejunum, approximately 59% of G atran -IR cells coexpressed CCK. G atran /CCK-IR cells were reduced in fasted and refed compared with controls (P < 0.01) in the jejunum. G atran /CCK-IR cells were not visualized in the pylorus and cardiac mucosa ( Fig. 4C and D) . Finally, occasional G atran /G agust -IR cells were detected in the pylorus (Fig. 4C and D) and duodenum ( Fig. 4E-H) , which expressed CgA-IR ( Fig. 4G and H) . Furthermore, the number of CCK-IR cells decreased in fasted versus control (19.3 AE 2.5 versus 10.3 AE 1, P < 0.01), while no changes were observed in refed versus fasted and control groups.
Discussion
Taste receptors are likely to represent an important mechanism for sensing nutrients and non-nutrients in the GI lumen and contribute to the initiation of appropriate physiological response of digestion/ absorption of nutrients or elimination of harmful substances via activation of neuronal and endocrine pathways. We showed that (a) changed the density of G atran -IR cells, effect that was statistically significant versus controls in most, but not all gut regions. These findings support the concept that TRs participate to chemosensing processes controlling multiple GI functions, including food intake and metabolism.
Our results expand previous reports of G atran or G agust in the rodent [3, [8] [9] [10] [11] 17] , pig [12, 13] and human [14] GI mucosa by showing a systematic analysis and characterization of mucosal cells expressing G atran in the pig intestine, an animal model closer to human than rodents, and providing evidence that the expression of this taste-related signalling molecule is modified by feeding and fasting. G atran -IR was predominantly in EECs, but the colocalization with CgA was not complete suggesting that G atran -IR is also in non-EECs (likely brush cells), as it has been shown for G agust in the mouse [10] . On the other hand, in the human colon [14] and pig small intestine [13] , G agust has been reported exclusively in EECs. G atran -IR cells had a different density throughout the gut, which was high in the stomach, decreased from the duodenum to the ileum, then increased from the caecum to the rectum. These findings are consistent with species and region differences and suggest that TRs exert distinct functions according to the gut region. Like G agust , G atran mediates signals initiated by tastants acting at T1Rs and the T2Rs [7, 18, 19] . Thus, G atran cells are likely to serve different chemosensitive modalities depending upon the luminal content and the TR stimulated [19] . The colocalization of G atran with GHR in the stomach, and CCK and SOM in the small intestine is in agreement with previous studies in rodents and human [8, 9, 11, 14] , and in EECs lines [20] . GHR is an orexigenic peptide regulating energy balance homeostasis [21] , GI motility and secretion [22] , and feeding behaviour [23] , in several species including pigs [24] . CCK exerts a prominent role in satiety conveying signals elicited by nutrients (e.g. fats and proteins) via sensory nerve pathways to the brain [25] . SOM inhibits gastric acid secretion, gastric emptying and smooth muscle contraction and GI hormone release [26] . Thus, the colocalization of G atran with these peptides is consistent with an involvement of TRs in the control of satiety and food intake, energy balance metabolism and GI secretion and motility. Food deprivation and refeeding alter the morphology of the weaned pig GI tract mucosa with fasting inducing mucosa atrophy in the upper small intestine and refeeding partially restoring it [27] . We demonstrated that 24 h fasting and 24 h refeeding modified the number of G atran -IR cells in most regions of the pig gut. The number of CgA-IR cells was not modified by fasting and refeeding in most regions with the exception of the caecum and descending colon, therefore it is unlikely that the reduction in G atran -IR cells observed in fasted and in some regions also in refed animals is due to mucosa atrophy or lack of mucosal restoration following refeeding, although this possibility cannot be excluded. Fasting induces multiple changes in the EEC system such as increasing GHR and lowering GAS/CCK [28, 29] peptides that influence feeding behaviour and colocalize with G atran -IR. Our results indicated that in the cardiac and pyloric mucosa, the number of G atran /GHR cells is greater in normally fed compared with 24 h fasted piglets; similarly, the overall density of GHR-IR cells was lower in fasted than fed or refed animals. However, the increased G atran /GHR-IR cell expression, as observed during refeeding state in our model, may not necessarily correspond to increased GHR plasma levels during fasting. A significant increase in plasma GHR was reported [30] in weaning pigs following 36 h fasting, with a decrease with 12 h fasting, indicating that the length of food deprivation affects GHR response. Animal ages might also affect hormonal responses to fasting, as young animals possess fewer energy reserves and less body fat, while having higher energy requirements in relation to rapid body growth [31] . Our data showed a significant reduction in G atran /CCK-IR cells and in CCK-IR cells overall in fasted and refed pigs compared with controls. This is in agreement with previous reports of a decrease in CCK plasma concentrations and mRNA expression during fasting, while returning to pre-fasting values after either 24 h refeeding in the rat small intestine [32] and 1 h refeeding in lactating sows [33] . However, the reasons why in this study we did not detect an increase in G atran /CCK-IR cells during refeeding remain to be elucidated. It is possible that factors such as caloric intake, type of diet and slaughter time after refeeding may contribute to explain why CCK cells do not return to prefasting values.
In summary, TRs and downstream molecules might exert a variety of functions ranging from sensing beneficial nutrients (e.g. sweet and umami), thus inducing secretion and motility to facilitate digestion, absorption and food intake, to detection of bitter, potentially harmful substances, thus inducing a defensive response. The latter could be in the form of inhibition of gastric emptying to reduce absorption, increase in intestinal secretion to facilitate elimination, vomiting or avoidance. Taste-related molecules in the distal colon and rectum could also serve as a line of defence against bacteria, which are particularly abundant in these regions. This is supported by the findings that quorum-sensing molecules produced by Gramnegative bacteria activate a GPCR-mediated signalling cascade in EEC lines, which is likely to involve T2R (Sternini C and Rozengurt E, unpublished). Further studies are required to better understand TR functions in the GI tract in response to feeding, including their regulation with specific dietary components in relationship to peptide release in different regions of the GI tract.
